MAPT and Stroke: Since our main interest was to explore the relationships between PSCI and neuroinflammation on 18F-THK-5351 PET imaging, we only enrolled amyloid-negative stroke patients without tauopathy presentations to reduce the possibility of 18F-THK-5351 binding to tau protein.